Emergent BioSolutions Inc. today announced that it has been awarded approximately $23 million to develop a novel multi-drug auto-injector for nerve agent antidote delivery. Emergent’s device is being designed for intramuscular self- [Read more]
A current Defense Threat Reduction Agency (DTRA) research effort, conducted by the U.S. Army Research Institute for Chemical Defense (USAMRICD), is exploring the decontamination properties of Veriox®, a topical antimicrobial, anti-infective and [Read more]
A pilot study conducted by the National Institute of Allergy and Infectious Diseases (NIAID) of an investigational medical countermeasure for Acute Radiation Syndrome (ARS) has shown promising results. ARS occurs following acute [Read more]
The Defense Threat Reduction Agency is seeking innovative technologies to accomplish automated text processing and visual analytics for biological materials situational awareness in support of the Biological Materials Information Program (BMIP). BMIP [Read more]
The U.S. military’s Joint Product Director for Biological Detection Systems (JPD-BDS) is conducting a market survey to identify sources capable of manufacturing fully automated biological warfare agent identifiers using Raman Spectroscopy. JPD-BDS [Read more]
The Defense Threat Reduction Agency (DTRA) is seeking potential sources for chemical and biological counter-weapons of mass destruction (CWMD) laboratory analysis services. Technologies are desired that can measure airborne chemical concentrations, determine [Read more]
The U.S. military is conducting a market survey seeking contractors to provide ISO/IEC 17025 accreditation of the Pentagon Force Protection Agency (PFPA) CBRNE Laboratory and Threat Agent Testing Laboratory Accreditation Program. Services [Read more]
Battelle and Nanotherapeutics, Inc. announced today that the organizations have entered an alliance to bring together core research, development, test and evaluation (RDT&E) and manufacturing capabilities needed to expedite the development of [Read more]
Battelle’s Hazardous Materials Research Center (HMRC) will host a Live-Agent Test Week April 17-21, 2017. The event is an opportunity for manufacturers and developers of personal protective equipment against Chemical, Biological, Radiological [Read more]
The Biomedical Advanced Research and Development Authority (BARDA) has updated a funding mechanism for advanced development of chemical threat medical countermeasures. This effort is part of a multi-year, multi-topic Broad Agency Announcement [Read more]
© 2017 Global Biodefense